Bank of New York Mellon Corp reduced its stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 25.0% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,031,827 shares of the company's stock after selling 343,581 shares during the quarter. Bank of New York Mellon Corp owned about 0.41% of Oscar Health worth $13,527,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds have also recently made changes to their positions in the stock. Raymond James Financial Inc. bought a new position in Oscar Health in the 4th quarter valued at approximately $6,613,000. PNC Financial Services Group Inc. raised its stake in Oscar Health by 20.5% during the 4th quarter. PNC Financial Services Group Inc. now owns 17,896 shares of the company's stock valued at $241,000 after buying an additional 3,040 shares during the last quarter. Swiss National Bank increased its stake in shares of Oscar Health by 3.1% in the 4th quarter. Swiss National Bank now owns 324,800 shares of the company's stock worth $4,365,000 after purchasing an additional 9,900 shares in the last quarter. Natixis Advisors LLC purchased a new stake in shares of Oscar Health in the 4th quarter worth $485,000. Finally, Cibc World Markets Corp purchased a new stake in shares of Oscar Health in the 4th quarter worth $251,000. 75.70% of the stock is owned by institutional investors.
Insider Transactions at Oscar Health
In other Oscar Health news, Director Elbert O. Jr. Robinson sold 25,000 shares of Oscar Health stock in a transaction on Monday, May 12th. The shares were sold at an average price of $16.43, for a total value of $410,750.00. Following the transaction, the director directly owned 64,512 shares of the company's stock, valued at approximately $1,059,932.16. The trade was a 27.93% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 24.39% of the stock is currently owned by insiders.
Oscar Health Trading Up 8.0%
NYSE OSCR traded up $1.18 during trading on Wednesday, hitting $15.88. The stock had a trading volume of 50,455,212 shares, compared to its average volume of 8,469,985. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.88 and a current ratio of 0.88. The stock has a market capitalization of $4.05 billion, a price-to-earnings ratio of 56.73 and a beta of 1.90. Oscar Health, Inc. has a one year low of $11.20 and a one year high of $23.79. The stock has a 50 day simple moving average of $16.10 and a 200 day simple moving average of $14.92.
Oscar Health (NYSE:OSCR - Get Free Report) last issued its earnings results on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, topping analysts' consensus estimates of $0.83 by $0.09. The business had revenue of $3 billion for the quarter, compared to analyst estimates of $2.87 billion. Oscar Health had a net margin of 1.22% and a return on equity of 10.59%. The company's quarterly revenue was up 42.2% compared to the same quarter last year. During the same period last year, the company posted $0.62 earnings per share. Sell-side analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current year.
Wall Street Analyst Weigh In
A number of equities research analysts have issued reports on OSCR shares. UBS Group reiterated a "sell" rating and issued a $11.00 price target (down previously from $15.00) on shares of Oscar Health in a research note on Tuesday, July 15th. Piper Sandler downgraded shares of Oscar Health from an "overweight" rating to a "neutral" rating and set a $14.00 price objective for the company. in a report on Monday, July 14th. Wells Fargo & Company downgraded shares of Oscar Health from an "equal weight" rating to an "underweight" rating and dropped their price objective for the company from $16.00 to $10.00 in a report on Friday, July 11th. Barclays dropped their price objective on shares of Oscar Health from $17.00 to $11.00 and set an "underweight" rating for the company in a report on Wednesday. Finally, Raymond James Financial downgraded Oscar Health from an "outperform" rating to a "market perform" rating in a research report on Tuesday, June 24th. Five investment analysts have rated the stock with a sell rating and three have assigned a hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Reduce" and an average target price of $11.92.
Read Our Latest Stock Report on Oscar Health
About Oscar Health
(
Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Recommended Stories
Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access